Found: 39
Select item for more details and to access through your institution.
Case Report: "Aggressive" perioperative antiseizure medication prophylaxis in patients with glioma-related epilepsy at high risk of early postoperative seizures following awake craniotomy.
- Published in:
- Frontiers in Surgery, 2024, p. 01, doi. 10.3389/fsurg.2023.1282013
- By:
- Publication type:
- Article
Clinical features and outcomes in primary nervous system histiocytic neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 4, p. 283, doi. 10.1093/nop/npy048
- By:
- Publication type:
- Article
Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 21, p. 7935, doi. 10.1002/cam4.3422
- By:
- Publication type:
- Article
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 457, doi. 10.1093/neuonc/noaa168
- By:
- Publication type:
- Article
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 4, p. 546, doi. 10.1093/neuonc/nox161
- By:
- Publication type:
- Article
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 5, p. 625, doi. 10.1093/neuonc/nox029
- By:
- Publication type:
- Article
Leptomeningeal metastases: a RANO proposal for response criteria.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 484, doi. 10.1093/neuonc/now183
- By:
- Publication type:
- Article
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 252, doi. 10.1093/neuonc/now236
- By:
- Publication type:
- Article
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 9, p. 1261, doi. 10.1093/neuonc/nou328
- By:
- Publication type:
- Article
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 9, p. 1176, doi. 10.1093/neuonc/nou089
- By:
- Publication type:
- Article
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 2, p. 215, doi. 10.1093/neuonc/nor198
- By:
- Publication type:
- Article
Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 2, p. 164
- By:
- Publication type:
- Article
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study.
- Published in:
- Neuro-Oncology, 2006, v. 8, n. 2, p. 189, doi. 10.1215/15228517-2005-010
- By:
- Publication type:
- Article
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 1, p. 44, doi. 10.1215/S1152851703000292
- By:
- Publication type:
- Article
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 1, p. 33, doi. 10.1215/S1152851703000309
- By:
- Publication type:
- Article
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 8, p. 1712
- By:
- Publication type:
- Article
Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Quality-of-lifeadjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 12, p. 3053
- By:
- Publication type:
- Article
Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 6, p. 1311, doi. 10.1002/cncr.10816
- By:
- Publication type:
- Article
Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption.
- Published in:
- Acta Neuropathologica, 1995, v. 89, n. 4, p. 341, doi. 10.1007/BF00309627
- By:
- Publication type:
- Article
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac041
- By:
- Publication type:
- Article
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 11, p. 1303, doi. 10.1002/jcph.543
- By:
- Publication type:
- Article
Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
- Published in:
- Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 573, doi. 10.1007/s11060-019-03194-z
- By:
- Publication type:
- Article
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 99, n. 1, p. 73, doi. 10.1007/s11060-009-0103-2
- By:
- Publication type:
- Article
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
- Published in:
- Journal of Neuro-Oncology, 2009, v. 92, n. 2, p. 165
- By:
- Publication type:
- Article
Anaplastic Oligodendrogliomas: Prognostic Factors for Tumor Recurrence and Survival.
- Published in:
- Oncology, 2003, v. 65, n. 3, p. 259, doi. 10.1159/000074479
- By:
- Publication type:
- Article
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 6, p. 855, doi. 10.1093/neuonc/noac004
- By:
- Publication type:
- Article
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Autoimmunity in paraneoplastic neurological syndromes: closer to the truth?
- Published in:
- 1999
- By:
- Publication type:
- commentary
Intravascular malignant lymphomatosis: Amelioration of neurological symptoms with plasmapheresis.
- Published in:
- Annals of Neurology, 1994, v. 35, n. 3, p. 357, doi. 10.1002/ana.410350318
- By:
- Publication type:
- Article
Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins.
- Published in:
- Annals of Neurology, 1993, v. 33, n. 4, p. 373, doi. 10.1002/ana.410330407
- By:
- Publication type:
- Article
Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer.
- Published in:
- Annals of Neurology, 1991, v. 29, n. 3, p. 241, doi. 10.1002/ana.410290303
- By:
- Publication type:
- Article
Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.
- Published in:
- Annals of Neurology, 1985, v. 18, n. 5, p. 592, doi. 10.1002/ana.410180513
- By:
- Publication type:
- Article
Evolution of computed tomographic abnormalities in leptomeningeal metastases.
- Published in:
- 1985
- By:
- Publication type:
- journal article